Cidara Therapeutics, Inc.

Biocon Limited

Seachaid Pharmaceuticals, Inc.

Karen Polowy

Balasingam Radhakrishnan

Kenneth Duke James, Jr

Anuradha Vaidya

Navdeep Balkrishna Malkar

Mark A Miller

Nnochiri Ekwuribe

Leo Pavliv

Kenneth D James

Monica Puskas

Michelle Ferro

Diti Aggarwal

Nnochiri N Ekwuribe

Nnochiril N Ekwuribe

Karen Puskas

Nnochirii N Ekwuribe

The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.

Dosing regimens for echinocandin class compounds

The invention features pharmaceutical compositions including (i) a drug, and (ii) a PEG fatty acid ester or PPG fatty acid ester in an amount sufficient to increase the oral bioavailability of the drug.

Pharmaceutical compositions and uses thereof

Fatty acid compositions for administration of of pharmaceutical agents, such as proteins and peptides, protein and peptide conjugates, and/or cation-polypeptide conjugate complexes. In particular, the invention provides a solid pharmaceutical composition formulated for oral administration by ingestion, having from about 0.1 to about 75% w/w fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent. Further, the invention provides a liquid pharmaceutical composition formulated for oral administration by ingestion, comprising: from about 0.1 to about 10% w/v fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent.

Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof

Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof

Growing community of inventors

Raleigh, NC, United States of America

Karen Polowy